-
Cases of Flu Continue to Mount Across America
drugs
January 02, 2020
Flu continues to spread throughout the United States and has reached elevated levels in nearly every state, according to the U.S. Centers for Disease Control and Prevention.
-
Sanofi Awarded $226 Million by HHS to Expand Pandemic Influenza Preparedness
americanpharmaceuticalreview
December 17, 2019
Sanofi Pasteur has entered into an agreement with the U.S. Department of Health and Human Services (HHS) to increase the company's domestic pandemic influenza vaccine production ...
-
Vaccitech Provides Update on Clinical Progress for its Two Phase 2 Universal Influenza Studies
b3cnewswire
November 26, 2019
Vaccitech Ltd, a clinical-stage T cell immunotherapy company developing products to treat and prevent cancer and infectious diseases, reports successful recruitment and vaccination for ...
-
Sanofi evaluates impact and prevention of influenza at ‘Options X’
biospectrumasia
September 05, 2019
Flu which can lead to pneumonia, heart attack and stroke is now preventable through Flublok®, the first recombinant Influenza Vaccine and Fluzone® High-Dose Vaccine (IIV3-HD)
-
ACIP Recommendations Updated for 2019-20 U.S. Flu Season
drugs
August 27, 2019
The recommendations of the Advisory Committee on Immunization Practices (ACIP) relating to the use of seasonal influenza vaccines in the United States have been updated for 2019 to 2020...
-
Educational Handout May Increase Receipt of Child Flu Shot
drugs
July 17, 2019
Providing an educational handout about influenza disease in the waiting room before a pediatric provider visit may increase receipt of child influenza vaccine...
-
Exposure to 2009 pH1N1 Vaccine During Pregnancy Seems Safe
drugs
July 12, 2019
Exposure to 2009 pH1N1 Vaccine During Pregnancy Seems Safe.
-
2018 to 2019 Influenza Season in U.S. Was Longest in 10 Years
drugs
June 21, 2019
2018 to 2019 Influenza Season in U.S. Was Longest in 10 Years.
-
Influenza A vaccine enters Phase IIb trial
europeanpharmaceuticalreview
June 10, 2019
Novel influenza A vaccine has been administered to first patients in Phase IIb trial.
-
Single vaccination approach developed to combat respiratory diseases
europeanpharmaceuticalreview
May 24, 2019
Scientists have developed a single vaccination approach to simultaneously combat influenza and pneumococcal infections.